ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.577G>A (p.Val193Ile)

gnomAD frequency: 0.00305  dbSNP: rs4988346
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 31
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000120406 SCV000150070 benign not specified 2017-05-14 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV001084461 SCV000153857 benign Familial cancer of breast; Fanconi anemia complementation group J 2024-02-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV000116161 SCV000185903 benign Hereditary cancer-predisposing syndrome 2014-08-04 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV000120406 SCV000314843 benign not specified criteria provided, single submitter clinical testing
Counsyl RCV000410926 SCV000489805 benign Fanconi anemia complementation group J 2016-05-25 criteria provided, single submitter clinical testing
Counsyl RCV000412457 SCV000489806 benign Ovarian neoplasm 2016-05-25 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000120406 SCV000889220 benign not specified 2021-08-09 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000116161 SCV000902553 benign Hereditary cancer-predisposing syndrome 2015-10-15 criteria provided, single submitter clinical testing
Mendelics RCV000990030 SCV001140794 likely benign Familial cancer of breast 2019-05-28 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000410926 SCV001287319 likely benign Fanconi anemia complementation group J 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000759713 SCV001474040 benign not provided 2022-03-07 criteria provided, single submitter clinical testing
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden RCV000759713 SCV002010893 likely benign not provided 2021-11-03 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001798360 SCV002043639 benign Breast and/or ovarian cancer 2023-05-01 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000759713 SCV002063644 likely benign not provided 2024-08-01 criteria provided, single submitter clinical testing BRIP1: BP4, BS2
Genetic Services Laboratory, University of Chicago RCV000120406 SCV002066921 benign not specified 2019-02-27 criteria provided, single submitter clinical testing
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State RCV002225334 SCV002505046 benign Hereditary breast ovarian cancer syndrome 2022-04-19 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000116161 SCV002533720 benign Hereditary cancer-predisposing syndrome 2020-10-09 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000120406 SCV002551207 likely benign not specified 2023-08-15 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV001084461 SCV002801283 likely benign Familial cancer of breast; Fanconi anemia complementation group J 2021-08-23 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV000990030 SCV004016915 benign Familial cancer of breast 2023-07-07 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV000990030 SCV004019479 benign Familial cancer of breast 2023-03-02 criteria provided, single submitter clinical testing This variant is considered benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. Homozygosity for this variant has been confirmed in one or more individuals lacking clinical features consistent with gene-specific recessive disease, indicating that this variant is unlikely to be pathogenic.
Breakthrough Genomics, Breakthrough Genomics RCV000759713 SCV005211185 likely benign not provided criteria provided, single submitter not provided
ITMI RCV000120406 SCV000084558 not provided not specified 2013-09-19 no assertion provided reference population
True Health Diagnostics RCV000116161 SCV000805254 likely benign Hereditary cancer-predisposing syndrome 2018-05-30 no assertion criteria provided clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001358435 SCV001554165 benign Malignant tumor of breast no assertion criteria provided clinical testing The BRIP1 p.Val193Ile variant was identified in 4 of 726 proband chromosomes (frequency: 0.006) from individuals with breast and prostate cancer and was present in 14 of 4556 control chromosomes (frequency: 0.003) from healthy individuals (Kote-Jarai 2009,Rutter 2003, Vahteristo 2006, Wong 2011). The variant was identified in dbSNP (rs4988346) as “with benign allele”, ClinVar (interpreted as "benign" by Invitae and 8 others and "likely benign" by True Health Diagnostics). The variant was identified in control databases in 986 of 277,084 chromosomes (9 homozygous) at a frequency of 0.004 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 13 of 24,026 chromosomes (freq: 0.0005), Other in 39 of 6462 chromosomes (freq: 0.006), Latino in 135 of 34,414 chromosomes (freq: 0.004), European in 650 of 126,616 chromosomes (freq: 0.005), Ashkenazi Jewish in 54 of 10,148 chromosomes (freq: 0.005), Finnish in 27 of 25,780 chromosomes (freq: 0.001), and South Asian in 68 of 30,782 chromosomes (freq: 0.002). The variant was not observed in the East Asian population. The p.Val193 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign.
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000759713 SCV001742962 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000759713 SCV001808455 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute RCV000120406 SCV001906447 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000759713 SCV001931320 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000759713 SCV001955968 likely benign not provided no assertion criteria provided clinical testing
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000120406 SCV002036294 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.